Alternative splicing (AS) regulation as a novel therapeutic target in soft-tissue sarcoma (STS).

Authors

null

David Silva Moura

Health Research Institute-Fundación Jiménez Díaz University Hospital, Autonomous University of Madrid (IIS-FJD, UAM), Madrid, Spain

David Silva Moura , Esther Martinez-Font , Carine Bossard , Antonio Rubio-Reyes , Jose Lucinio Mondaza-Hernandez , Marta Martin-Ruiz , Pablo Romero-Gonzalez , Marta Renshaw-Calderon , Jaime Carrillo-Garcia , Davide Di Lernia , Nadia Hindi , Antonia Obrador , Javier Martin Broto

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Molecular Targets/Biomarkers/Tumor Biology

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 11546)

DOI

10.1200/JCO.2023.41.16_suppl.11546

Abstract #

11546

Poster Bd #

480

Abstract Disclosures

Similar Posters

Poster

2016 ASCO Annual Meeting

Trabectedin for advanced soft-tissue sarcoma: A single-center experience of over 10 years.

Trabectedin for advanced soft-tissue sarcoma: A single-center experience of over 10 years.

First Author: Imran Syed

First Author: Sant P. Chawla

First Author: Emanuela Palmerini